SCILEX HOLDING COMPANY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7454 USD | -10.21% |
|
-13.33% | -63.46% |
| Apr. 16 | Scilex Issues Preliminary Q1 Sales Results for ZTlido | MT |
| Mar. 20 | Scilex Seeks FDA Approval to Add Dosing Guidance to Gout Treatment Drug Label | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SCILEX HOLDING COMPANY | Specialty & Advanced Pharmaceuticals | -10.21% | -13.33% | -63.46% | -86.04% | - | 90.28M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- SCLX Stock
- Charts Scilex Holding Company
- Comparison Chart